These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27076171)

  • 1. Practical Approaches to Forced Degradation Studies of Vaccines.
    Hasija M; Aboutorabian S; Rahman N; Ausar SF
    Methods Mol Biol; 2016; 1403():853-66. PubMed ID: 27076171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation of therapeutic proteins.
    Hawe A; Wiggenhorn M; van de Weert M; Garbe JH; Mahler HC; Jiskoot W
    J Pharm Sci; 2012 Mar; 101(3):895-913. PubMed ID: 22083792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation studies of biopharmaceuticals: Selection of stress conditions.
    Tamizi E; Jouyban A
    Eur J Pharm Biopharm; 2016 Jan; 98():26-46. PubMed ID: 26542454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current regulatory requirements and practical approaches for stability analysis of pharmaceutical products: A comprehensive review.
    Sengupta P; Chatterjee B; Tekade RK
    Int J Pharm; 2018 May; 543(1-2):328-344. PubMed ID: 29635054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the forced degradation behavior of prasugrel hydrochloride by liquid chromatography with mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products.
    Singh DK; Sahu A; Handa T; Narayanam M; Singh S
    J Sep Sci; 2015 Sep; 38(17):2995-3005. PubMed ID: 26114771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stressed Stability Techniques for Adjuvant Formulations.
    Hasija M; Sheung A; Rahman N; Ausar SF
    Methods Mol Biol; 2017; 1494():227-238. PubMed ID: 27718197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.
    Jocić B; Zecević M; Zivanović L; Protić A; Jadranin M; Vajs V
    J Pharm Biomed Anal; 2009 Nov; 50(4):622-9. PubMed ID: 19250786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies.
    Kumru OS; Joshi SB; Smith DE; Middaugh CR; Prusik T; Volkin DB
    Biologicals; 2014 Sep; 42(5):237-59. PubMed ID: 24996452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability testing requirements for vaccines--draft guidelines of the International Conference on Harmonization.
    Haase M
    Dev Biol Stand; 1996; 87():309-18. PubMed ID: 8854031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Degradation Chemistry of Farglitazar and Elucidation of the Oxidative Degradation Mechanisms.
    Reynolds DW; Campbell JM; Johnson BS; Joshi BK; Facchine KL; Long S; O'Connell TM; Paulus IV; Sides SL; Kraft ES; Wolters AM
    J Pharm Sci; 2017 Apr; 106(4):982-993. PubMed ID: 27988163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS/MS characterization of forced degradation products of zofenopril.
    Ramesh T; Nageswara Rao P; Nageswara Rao R
    J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of protein stability in rod-insert vaginal rings.
    Pattani A; Lowry D; Curran RM; McGrath S; Kett VL; Andrews GP; Malcolm RK
    Int J Pharm; 2012 Jul; 430(1-2):89-97. PubMed ID: 22486955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal stability of vaccines.
    Brandau DT; Jones LS; Wiethoff CM; Rexroad J; Middaugh CR
    J Pharm Sci; 2003 Feb; 92(2):218-31. PubMed ID: 12532371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of two new forced degradation products of letrozole and development of a stability-indicating RP-LC method for its determination.
    Elkady EF; Fouad MA
    Pak J Pharm Sci; 2015 Nov; 28(6):2041-51. PubMed ID: 26639498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
    Bhardwaj SP; Singh S
    J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.
    Cleland JL; Powell MF; Shire SJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(4):307-77. PubMed ID: 8124728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validated stability indicating ion-pair RP-LC method for zoledronic acid.
    Rao BM; Srinivasu MK; Rani ChP; kumar SS; Kumar PR; Chandrasekhar KB; Veerender M
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):781-90. PubMed ID: 15922532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches.
    Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR
    J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.